Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
GRC 54276 has shown tumour cell killing ability in preclinical studies as a single agent and as well in combination with checkpoint inhibitors, making it a high-priority target in immuno-oncology
The groundbreaking, uniquely robust Robert A. Winn Diversity in Clinical Trials Award Program is on track to train more than 500 individuals from diverse backgrounds by 2027
Results from pre-clinical research show iron-like compound hold promise for treating patients with glioblastoma, an aggressive brain cancer
CanSinoBIO will continue to focus on developing a variety of innovative preventive vaccines in its diversified product pipeline with proprietary technologies, including the inhaled version of its COVID-19 vaccine, Convidecia
Clinical trials for minimally invasive therapy procedures using advanced imaging from Philips Lung Suite start with successful first cases
The implementation of ScienceMedia's solutions will ultimately help AMCR collapse patient recruitment and enrollment
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months
With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies
Subscribe To Our Newsletter & Stay Updated
